The Therapeutic Inhibitor for Epstein-Barr Virus (EBV)
Department of Chemistry
用於治療EB病毒的抑制劑 The Therapeutic Inhibitor for Epstein-Barr Virus (EBV)
Prof. Wong Ka Leung, Dr. Lung Hong Lok
PROJECT YEAR :
Open to all
EBV is a ubiquitous human herpes virus, which spreads through saliva. Infection is very common and most people get EBV when they were young, but they will not experience any symptoms until they get older.
As one of eight known human herpes virus types in the herpes family, EBV infects over 90% of the human population. Nasopharyngeal Cancer (NPC) is one of EBV associated cancers where the highest NPC incidence rate is found in South China including Hong Kong. Early detection and treatment contribute to a higher survival rate.
Prof. Wong and Dr. Lung have invented new EBV-specific targeted therapy which specifically kills cancer cells without affecting any normal cells. The uptake of this drug can also be traced by the fluorescent signal and that can be used for cancer cells imaging.
This video is presented here with the permission of the producers.
Any downloading, storage, reproduction, and redistribution are strictly prohibited
without the prior permission of the respective producers.
Go to Full Disclaimer.
This video is archived and disseminated for educational purposes only. It is presented here with the permission of the producers.
Statements of fact and opinions expressed are those of the individual participants. The HKBU and its Library assume no responsibility for the accuracy, validity, or completeness of the information presented.
Any downloading, storage, reproduction, and redistribution, in part or in whole, are strictly prohibited without the prior permission of the respective producers. Please strictly observe the copyright law.